NasdaqGS - Nasdaq Real Time Price USD
AbCellera Biologics Inc. (ABCL)
Tune into live earnings calls Now streaming directly on quote pages.
2.0100
0.0000
(0.00%)
At close: 4:00:00 PM EDT
1.9900
-0.02
(-1.00%)
After hours: 4:30:11 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 5 |
| Avg. Estimate | -0.14 | -0.14 | -0.66 | -0.59 |
| Low Estimate | -0.19 | -0.18 | -0.8 | -0.76 |
| High Estimate | -0.11 | -0.12 | -0.46 | -0.39 |
| Year Ago EPS | -0.14 | -0.13 | -0.55 | -0.66 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 6 | 9 | 7 |
| Avg. Estimate | 7.31M | 6.87M | 26.81M | 37.11M |
| Low Estimate | 4.6M | 4.67M | 17.8M | 22.96M |
| High Estimate | 17M | 12M | 50M | 60M |
| Year Ago Sales | 9.95M | 7.32M | 28.83M | 26.81M |
| Sales Growth (year/est) | -26.56% | -6.24% | -7.01% | 38.43% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.14 | -0.13 | -0.15 |
| EPS Actual | -0.14 | -0.13 | -0.17 | -0.12 |
| Difference | 0.02 | 0.01 | -0.04 | 0.03 |
| Surprise % | 13.28% | 9.30% | -30.77% | 20.76% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.14 | -0.14 | -0.66 | -0.59 |
| 7 Days Ago | -0.14 | -0.14 | -0.66 | -0.59 |
| 30 Days Ago | -0.14 | -0.14 | -0.66 | -0.59 |
| 60 Days Ago | -0.17 | -0.19 | -0.68 | -0.56 |
| 90 Days Ago | -0.17 | -0.19 | -0.68 | -0.56 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | 2 | 2 |
| Down Last 30 Days | -- | -- | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABCL | -1.79% | -11.54% | -20.61% | 10.75% |
| S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Upgrades & Downgrades
| Maintains | Keybanc: Overweight to Overweight | 4/16/2025 |
| Reiterates | Benchmark: Hold to Hold | 3/3/2025 |
| Maintains | Stifel: Buy to Buy | 2/28/2025 |
| Maintains | Keybanc: Overweight to Overweight | 1/8/2025 |
| Reiterates | Benchmark: Hold | 11/5/2024 |
| Reiterates | Stifel: Buy to Buy | 11/5/2024 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
8.28
+13.58%
DNA Ginkgo Bioworks Holdings, Inc.
7.87
+6.35%
BEAM Beam Therapeutics Inc.
17.25
+6.32%
ABSI Absci Corporation
2.8000
+5.26%
VERV Verve Therapeutics, Inc.
4.4800
+6.16%
VIR Vir Biotechnology, Inc.
5.41
-3.57%
CRBU Caribou Biosciences, Inc.
0.7900
+3.95%
PRME Prime Medicine, Inc.
1.3200
-7.04%
EDIT Editas Medicine, Inc.
1.3900
+4.51%
SGMO Sangamo Therapeutics, Inc.
0.7198
+10.67%